Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3351059
Max Phase: Preclinical
Molecular Formula: C41H53N5O7
Molecular Weight: 727.90
Molecule Type: Small molecule
Associated Items:
ID: ALA3351059
Max Phase: Preclinical
Molecular Formula: C41H53N5O7
Molecular Weight: 727.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1cccc2ccccc12)N(C)C)C(=O)N(C)[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC(C)(C)C
Standard InChI: InChI=1S/C41H53N5O7/c1-8-9-20-32(39(51)46(7)35(40(52)53-41(2,3)4)23-28-25-42-31-21-13-12-19-30(28)31)43-37(49)33(24-36(47)48)44-38(50)34(45(5)6)22-27-17-14-16-26-15-10-11-18-29(26)27/h10-19,21,25,32-35,42H,8-9,20,22-24H2,1-7H3,(H,43,49)(H,44,50)(H,47,48)/t32-,33-,34-,35-/m0/s1
Standard InChI Key: JXEXTQCXQJHWAX-BBACVFHCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 727.90 | Molecular Weight (Monoisotopic): 727.3945 | AlogP: 4.84 | #Rotatable Bonds: 17 |
Polar Surface Area: 161.14 | Molecular Species: ACID | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.34 | CX Basic pKa: 7.39 | CX LogP: 2.57 | CX LogD: 2.33 |
Aromatic Rings: 4 | Heavy Atoms: 53 | QED Weighted: 0.11 | Np Likeness Score: 0.13 |
1. Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP.. (1993) CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives., 36 (1): [PMID:8421283] [10.1021/jm00053a022] |
Source(1):